Ranaz Announces Nationwide Voluntary Recall of Pro-Amino Supreme Peanut, Pro-Amino Crunchy Cereal Caramel, Protidiet Supreme Peanut, Protidiet Crunchy Cereal Caramel, ProtiLife Caramel Peanut Crunch Cereal and ProtiLife Peanut Butter Bars Due to Possible Peanut Corporation of America (PCA) Contamination and Potential Health Risk



    No Cases of Illness Reported

    MONTREAL, Jan. 30 /CNW Telbec/ - Ranaz Corporation ("Ranaz") (TSX-V: RNZ)
today announced a voluntary recall of the following bars:

    Pro-Amino Supreme Peanut and Protidiet Supreme Peanut: lot codes PN 08 7
A, PN 09 7 A, PN 25 7 A, PN 26 7 A, PN 12 7 D, PN 07 7 H, PN 08 7 H, PN 17 7
I, PN 05 7 L, PN 02 8 D, PN 13 8 F, PN 13 8 H, PN 19 8 H, PN 18 8 I, PN 25 8
I, PN 12 08 K.

    Pro-Amino Crunchy Cereal Caramel and Protidiet Crunchy Cereal Caramel:
lot codes 11 7 A, 02 7 B, 05 7 B,14 7 E, 18 7 F, 06 7 H, 07 7 H, 18 7 I, 23 7
J, 04 7 L, 06 7 L, 07 7 L, 05 8 C, 29 8 D, 30 8 D, 30 8 E, 20 8 H, 26 8 H, 26
8 I, 18 8 L.

    ProtiLife Caramel Peanut Crunch Cereal: lot codes CP 05 7 C, CP 08 7 C,
CP 21 7 C, CP 26 7 C, CP 27 7 K, CP 10 8 A, CP 11 8 A, CP 25 8 D, CP 06 8 F,
CP 26 8 H, CP 18 8 I.

    ProtiLife Peanut Butter: lot codes BA 05 7 C, BA 23 7 C, BA 27 7 K, BA 28
7 K, BA 10 8 A, BA 29 8 D, BA 12 8 E, BA 06 8 F, BA 09 8 J, BA 18 8 L.

    These bars have been recalled because the product contains peanut
ingredients which were manufactured by Peanut Corporation of America (PCA),
which is the focus of an ongoing Salmonella investigation by the United States
Food & Drug Administration (FDA) and the Canadian Food Inspection Agency
(CFIA). PCA is one of the suppliers of peanut ingredients to the company's
subcontractor for those bars. Ranaz's subcontractor for those bars is no
longer using PCA as a supplier.
    Food contaminated with Salmonella may not look or smell spoiled.
Consumption of food contaminated with this bacteria may cause salmonellosis, a
foodborne illness. In young children, the elderly and people with weakened
immune systems, salmonellosis may cause serious and sometimes deadly
infections. In otherwise healthy people, salmonellosis may cause short-term
symptoms such as high fever, severe headache, vomiting, nausea, abdominal pain
and diarrhea. Long-term complications may include severe arthritis.
    There have been no cases of illness or adverse effects reported by any
Ranaz customers, and no other products, including those made with peanut
butter, are affected by this recall. This voluntary recall is in line with
CFIA recommendations, and Ranaz has removed all products within existing
inventory.
    "The safety of our customers is our highest priority, and in keeping with
the recommendations by the CFIA, we are urging all consumers who have
purchased or are in possession of this product to return them to us," said
Martin Vidal, Executive Vice-President and CFO of Ranaz. "Customers seeking a
replacement bar are being asked to call Line Forget at Ranaz at 450-491-7106,
ext. 259 or e-mail l.forget@ranazcorporation.com and a replacement bar will be
issued in its place."

    About Ranaz Corporation

    Ranaz is a company specializing in the manufacture and marketing of
protein and dietary supplements. Its mission is to design, develop and market
nutritional, protein and dietary supplements under its own corporate brands
and concepts, such as Protidiet and ProtiLife, as well as under private
labels. For more information about the Company, please visit our website at
www.ranazcorporation.com.

    Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may constitute
forward-looking statements. Such statements, based as they are on the current
expectations of management, inherently involve numerous risks and
uncertainties, known and unknown, many of which are beyond Ranaz's control.
Such risks include but are not limited to: the impact of general economic
conditions, changes in the regulatory environment in the jurisdictions in
which Ranaz does business, stock markets volatility, fluctuations in costs,
and changes to the competitive environment due to consolidation, as well as
other risks disclosed in public filings of Ranaz. Consequently, actual future
results may differ materially from the anticipated results expressed in the
forward-looking statements. The reader should not place undue reliance, if
any, on the forward-looking statements included in this news release. These
statements speak only as of the date made and Ranaz is under no obligation and
disavows any intention to update or revise such statements as a result of any
event, circumstances or otherwise.

    The TSX Venture Exchange has not reviewed and does not accept
    responsibility for the adequacy or accuracy of this release.
    %SEDAR: 00024418EF




For further information:

For further information: Ranaz Corporation: Martin Vidal, Executive Vice
President and Chief Financial Officer, (450) 491-7106, Ext. 213,
martinv@ranazcorporation.com; SOLAK Communications: François Kalos, President,
(450) 993-0828, kalos@solak.ca

Organization Profile

Ranaz Corporation

More on this organization

Recalls

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890